Therefore, the inhibition of lipophagy along with the continuous production of small LDs engulfed by PLIN2, PLIN3, and PLIN5 could be a proposed mechanism for NAFLD progression from simple steatosis to NASH. The gene discussed is PLIN2; the disease is metabolic dysfunction-associated steatotic liver disease.